Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ecubectedin by Pharma Mar for Small-Cell Lung Cancer: Likelihood of Approval
Ecubectedin is under clinical development by Pharma Mar and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...
Data Insights
Risk adjusted net present value: What is the current valuation of Pharma Mar's Ecubectedin?
Ecubectedin is a small molecule commercialized by Pharma Mar, with a leading Phase II program in Ductal Carcinoma. According to...